Bladder Cancer Clinical Trials

1142 clinical trials for Bladder Cancer across international registries, including 204 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Guiding Value of Urinary Tumor DNA Testing in Repeat Transurethral Resection of Non-Muscle-Invasive Bladder Cancer — RECRUITING · NA
• Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy — RECRUITING
• A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031) — RECRUITING · PHASE3
• En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device — RECRUITING
• Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease — RECRUITING
• Luminal Bladder Cancer Effective Response to Neoadjuvant Chemotherapy (LUMBER-NAC) — RECRUITING · PHASE2
• Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial — RECRUITING · NA
• Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue — RECRUITING
• A Study of MGC026 in Participants With Advanced Solid Tumors — RECRUITING · PHASE1
• TReatment Approaches and bIomarkers preValence in bladdEr Cancer in RuSsian Federation — RECRUITING
• A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors — RECRUITING · PHASE2
• A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies — RECRUITING
• Evaluation for NCI Surgery Branch Clinical Research Protocols — RECRUITING
• A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas — RECRUITING · PHASE1
• A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors — RECRUITING · PHASE1
• A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors — RECRUITING · PHASE1
• IDOV-Immune for Advanced Solid Tumors — RECRUITING · PHASE1
• The Global En Bloc Resection of Bladder Tumour Registry — RECRUITING
• A Study of a Side Effects and Resource Navigation Program for People With Cancer — RECRUITING · NA
• Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2 — RECRUITING
• Study Investigating Intravesical HDAC Inhibition to Improve Response to Immuno-Oncology Agents — RECRUITING · PHASE1
• Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors — RECRUITING · PHASE1
• Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma — RECRUITING · PHASE2
• Development of an AI-Agent for Urological Disease Diagnosis and Treatment — RECRUITING
• DESTINY-PANTUMOUR04 — RECRUITING
• A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors — RECRUITING · PHASE1
• Sun Yat-Sen Treatment Strategy for Enhancing Response in Muscle-invasive Bladder Cancer — RECRUITING · PHASE2
• Toripalimab Combined With BCG Perfusion for the Treatment of HR-NMIBC After TURBT Surgery Exploration — RECRUITING · PHASE2
• Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors — RECRUITING · PHASE1
• A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003) — RECRUITING · PHASE1
• PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival — RECRUITING · NA
• A Study of Surgical Techniques During Cystectomy — RECRUITING · PHASE3
• SL-28 for Advanced Solid Tumours — RECRUITING · PHASE1
• Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors — RECRUITING · NA
• Predicting BCG Response — RECRUITING
• Non-invasive Urinary Genomics-Based Risk Assessment for Early Urothelial Carcinoma Diagnosis — RECRUITING
• Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05) — RECRUITING
• Integrated Cancer Repository for Cancer Research — RECRUITING
• Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer — RECRUITING
• KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04) — RECRUITING · PHASE1
• Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer — RECRUITING · PHASE2
• Intervention of Bladder Cancer by CAR-T — RECRUITING · PHASE1
• Impact of COMORBIDities After Radical Cystectomy Using a Predictive Method With Artificial Intelligence — RECRUITING
• DURvalumab in Combination With S-488210/S-488211 vAccine in Non-muscle Invasive Bladder CancEr — RECRUITING · PHASE1
• Local Radiotherapy for Urinary Bladder Cancer in Patients Not Eligible for Curative Treatment — RECRUITING · NA
• The Clinical Effectiveness and Safety of Intravesical Mitomycin-C and Gemcitabine Sequential Therapy — RECRUITING · PHASE2
• Trop2-targeted immunoPET Imaging of Solid Tumors — RECRUITING · PHASE2
• Urinary Tumor DNA-Guided Systemic Immunotherapy for Unresectable Very-High-Risk Non-Muscle-Invasive Bladder Cancer — RECRUITING · PHASE2
• Comparison of CT and MR (VI-RADS) Imaging for Local Bladder Cancer Staging — RECRUITING
• 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection — RECRUITING · PHASE2

Refine this search